About Wallace Laboratories Private Limited
Data last updated:
Wallace Laboratories Private Limited was a private limited company based in Goa, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 April 1996.
The company was registered with the Registrar of Companies (ROC), Goa, under CIN U33112GA1996PTC002077. Its GSTIN is 29AAACW3431A1ZR (Karnataka). The company held 3 GST registrations, of which 1 is active.
The company had an authorised share capital of ₹25 Lakh and a paid-up capital of ₹8.37 Lakh. It was led by directors including Vinay Pinto (Managing Director) and Rajashekhar Rayanagoudar Basanagouda.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 3rd Floor Dtc. Building Patto Plaza Edc Complex Panaji, Goa, India – 403001.
As per the financials filed for FY 2023, the company reported a revenue of ₹22.71 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹4.18 Cr (net margin 18.4%) and EBITDA of ₹7.49 Cr (EBITDA margin 33%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 9% over five years.
The company had about 101 employees on its provident fund (EPFO) records before it was dissolved.
As per MCA filings, the company had satisfied charges of ₹5.25 Cr on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 1 case is pending.
The last known website on record is wallacepharma.com.
Company details
Contact details
Wallace Laboratories Private Limited's registered office is in Goa. Its website is wallacepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address3rd Floor Dtc. Building Patto Plaza Edc Complex Panaji, Goa, India – 403001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Wallace Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Wallace Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Wallace Laboratories Private Limited, buy the company report.
Financials of Wallace Laboratories Private Limited
FY 2023 filings availableWallace Laboratories Private Limited reported revenue of ₹22.71 Cr (up 27% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 27% growth in the latest year. EBITDA rose 87% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹22.71 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.49 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.18 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 33% | ||||
| Net Profit Margin | 18.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wallace Laboratories Private Limited, buy the company report.
Board of directors of Wallace Laboratories Private Limited
Wallace Laboratories has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajashekhar Rayanagoudar Basanagouda Also directs: Wallace Pharmaceuticals Private Limited | Director | 23 May 2016 | 10 Years 5 Months | As last reported |
| Vinay Pinto Also directs: Wallace Pharmaceuticals Private Limited | Managing Director | 19 Aug 2021 | 5 Years 2 Months | As last reported |
| Rashmi Menezes Also directs: Wallace Pharmaceuticals Private Limited | Director | 19 Aug 2021 | 5 Years 2 Months | As last reported |
| Maria Emilia Dias Menezes | Director | 15 Mar 2006 | 20 Years 7 Months | As last reported |
| Cesar Mauricio Jose De Menezes | Director | 15 Mar 2006 | 20 Years 7 Months | As last reported |
Peer comparison
Wallace Laboratories Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cent Cure Private Limited | ₹22.88 Cr (FY 2025) | 17.0% | Baddi, Himachal Pradesh, India | |||
| Inga Laboratories Private Limited | ₹22.8 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Franklin Laboratories India Pvt Ltd | ₹22.76 Cr (FY 2025) | -5.0% | Punjab, India | |||
| Wallace Laboratories Private Limitedthis company | ₹22.71 Cr (FY 2023) | ₹4.18 Cr | 18.4% | 27.0% | 101 | Goa, India |
| Dr. Smiths Biotech Private Limited | ₹22.7 Cr (FY 2023) | 40.0% | Pune, Maharashtra, India | |||
| Astamed Healthcare ( India ) Private Limited | ₹22.66 Cr (FY 2025) | -10.0% | Mumbai, Maharashtra, India | |||
| Disto Pharmaceuticals Private Limited | ₹22.63 Cr (FY 2024) | -5.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Wallace Laboratories Private Limited, buy the company report.
Auditor
Wallace Laboratories Private Limited is audited by Y.N. UPADHYAYA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Y.N. UPADHYAYA & CO | FY 2023 | 111173W |
Shareholding
The shareholding of Wallace Laboratories Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Wallace Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Mar 2006 | 10019076 | Bank of Baroda | ₹3 Cr | Satisfied | |
| 28 Mar 2003 | 90076404 | Bank of Baroda | ₹2.25 Cr | Satisfied |
To see the full charge records of Wallace Laboratories Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Wallace Laboratories Private Limited has 6 court cases on record: 2 filed by Wallace Laboratories, 4 filed against it. 1 case is pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 0 |
| Supreme Court | 2 | 1 | 1 |
| District courts | 1 | 0 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0104-Labour Matters : Matters relating to wages, bonus, ad-hoc, casual daily wages & their regularisation) | Filed against the company by Group Pharmaceuticals Ltd. Managing Directors 521/A, 2Nd Block, 2Nd Main 2Nd Stage Rajaji Nagar Bengaluru-560055 ,Bangalore , Karnataka and 10 others | Disposed |
| Supreme Court | Appeal | Filed by the company against Commissioner of Central Excise | Pending |
| High Court of Karnataka | Appeal | Filed against the company | Disposed |
| High Court of Karnataka | Writ petition | Filed against the company | Disposed |
| District court, DHARWAD, Karnataka | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Wallace Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wallace Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Wallace Laboratories Private Limited has a workforce of 101 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Wallace Laboratories has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACW3431A1ZR | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Wallace Laboratories Private Limited, buy the company report.
Recent activity
Wallace Laboratories Private Limited has 11 board changes on record since 2006: 5 appointments and 6 cessations. The latest: Rashmi Menezes ceased to be Additional Director on 06 Sep 2022.
7 earlier events are in the company report.
Frequently asked questions
Wallace Laboratories has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Wallace Laboratories was a private limited company based in Goa, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 16 April 1996 and is registered under CIN U33112GA1996PTC002077. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Wallace Laboratories was incorporated on 16 April 1996. It is registered with the Registrar of Companies, Goa.
Wallace Laboratories had 5 directors:
- Vinay Pinto - Managing Director
- Rajashekhar Rayanagoudar Basanagouda - Director
- Rashmi Menezes - Director
- Maria Emilia Dias Menezes - Director
- Cesar Mauricio Jose De Menezes - Director
The CIN (Corporate Identification Number) of Wallace Laboratories is U33112GA1996PTC002077. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Wallace Laboratories is at 3rd Floor Dtc. Building Patto Plaza Edc Complex Panaji, Goa, India – 403001.
Wallace Laboratories can be reached through the website wallacepharma.com. Its registered office is in Goa, India.
The latest financial statements of Wallace Laboratories on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Wallace Laboratories is 29AAACW3431A1ZR, registered in Karnataka. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
Wallace Laboratories operated in the pharma industry, in the drug formulation and development segment.
The peers of Wallace Laboratories by revenue are Cent Cure Private Limited, Inga Laboratories Private Limited, Franklin Laboratories India Pvt Ltd, Dr. Smiths Biotech Private Limited, Astamed Healthcare ( India ) Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
